Literature DB >> 21223531

The ecology and pathobiology of Clostridium difficile infections: an interdisciplinary challenge.

E R Dubberke1, D B Haslam, C Lanzas, L D Bobo, C-A D Burnham, Y T Gröhn, P I Tarr.   

Abstract

Clostridium difficile is a well recognized pathogen of humans and animals. Although C. difficile was first identified over 70 years ago, much remains unknown in regards to the primary source of human acquisition and its pathobiology. These deficits in our knowledge have been intensified by dramatic increases in both the frequency and severity of disease in humans over the last decade. The changes in C. difficile epidemiology might be due to the emergence of a hypervirulent stain of C. difficile, ageing of the population, altered risk of developing infection with newer medications, and/or increased exposure to C. difficile outside of hospitals. In recent years, there have been numerous reports documenting C. difficile contamination of various foods, and reports of similarities between strains that infect animals and strains that infect humans as well. The purposes of this review are to highlight the many challenges to diagnosing, treating, and preventing C. difficile infection in humans, and to stress that collaboration between human and veterinary researchers is needed to control this pathogen.
© 2010 Blackwell Verlag GmbH.

Entities:  

Mesh:

Year:  2010        PMID: 21223531      PMCID: PMC3668351          DOI: 10.1111/j.1863-2378.2010.01352.x

Source DB:  PubMed          Journal:  Zoonoses Public Health        ISSN: 1863-1959            Impact factor:   2.702


  187 in total

Review 1.  Clostridium difficile enteritis after colectomy.

Authors:  M Wayne Causey; Michael P Spencer; Scott R Steele
Journal:  Am Surg       Date:  2009-12       Impact factor: 0.688

2.  Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.

Authors:  Mark Miller; Denise Gravel; Michael Mulvey; Geoffrey Taylor; David Boyd; Andrew Simor; Michael Gardam; Allison McGeer; James Hutchinson; Dorothy Moore; Sharon Kelly
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

Review 3.  Clostridium difficile in food--innocent bystander or serious threat?

Authors:  J S Weese
Journal:  Clin Microbiol Infect       Date:  2010-01       Impact factor: 8.067

4.  Varied prevalence of Clostridium difficile in an integrated swine operation.

Authors:  K N Norman; R B Harvey; H M Scott; M E Hume; K Andrews; A D Brawley
Journal:  Anaerobe       Date:  2009-09-22       Impact factor: 3.331

5.  Emergency subtotal colectomy for fulminant Clostridium difficile colitis--is a surgical solution considered for all patients?

Authors:  K Gash; E Brown; A Pullyblank
Journal:  Ann R Coll Surg Engl       Date:  2010-01       Impact factor: 1.891

6.  The fascination with probiotics for Clostridium difficile infection: lack of evidence for prophylactic or therapeutic efficacy.

Authors:  Mark Miller
Journal:  Anaerobe       Date:  2009-08-20       Impact factor: 3.331

7.  Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection.

Authors:  Elizabeth J Kvach; David Ferguson; Paul F Riska; Marie L Landry
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

8.  Diversity of Clostridium difficile in pigs and other animals in Slovenia.

Authors:  Jana Avbersek; Sandra Janezic; Mateja Pate; Maja Rupnik; Valerija Zidaric; Katarina Logar; Modest Vengust; Mateja Zemljic; Tina Pirs; Matjaz Ocepek
Journal:  Anaerobe       Date:  2009-07-24       Impact factor: 3.331

Review 9.  Intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis: an observational study and review of the literature.

Authors:  Marwan S Abougergi; Apoorv Broor; Wei Cui; Bernard G Jaar
Journal:  J Hosp Med       Date:  2010-01       Impact factor: 2.960

10.  Piglet models of acute or chronic Clostridium difficile illness.

Authors:  Jennifer Steele; Hanping Feng; Nicola Parry; Saul Tzipori
Journal:  J Infect Dis       Date:  2010-02-01       Impact factor: 5.226

View more
  15 in total

1.  Sensitivity to antibiotics of Clostridium difficile toxigenic nosocomial strains.

Authors:  Vladimir Beran; Dittmar Chmelar; Jana Vobejdova; Adela Konigova; Jakub Nemec; Josef Tvrdik
Journal:  Folia Microbiol (Praha)       Date:  2013-10-11       Impact factor: 2.099

2.  Optimal control of vaccination rate in an epidemiological model of Clostridium difficile transmission.

Authors:  Brittany Stephenson; Cristina Lanzas; Suzanne Lenhart; Judy Day
Journal:  J Math Biol       Date:  2017-05-08       Impact factor: 2.259

3.  Diarrhea etiology in a pediatric emergency department: a case control study.

Authors:  Donna M Denno; Nurmohammad Shaikh; Jenny R Stapp; Xuan Qin; Carolyn M Hutter; Valerie Hoffman; Jody C Mooney; Kelly M Wood; Harold J Stevens; Robert Jones; Phillip I Tarr; Eileen J Klein
Journal:  Clin Infect Dis       Date:  2012-06-14       Impact factor: 9.079

4.  Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile.

Authors:  Melinda A Engevik; Kristen A Engevik; Mary Beth Yacyshyn; Jiang Wang; Daniel J Hassett; Benjamin Darien; Bruce R Yacyshyn; Roger T Worrell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-31       Impact factor: 4.052

5.  Isolation and characterization of Clostridium difficile from shellfish and marine environments.

Authors:  Vincenzo Pasquale; Vincenza Jessica Romano; Maja Rupnik; Stefano Dumontet; Ivan Cižnár; F Aliberti; F Mauri; V Saggiomo; Karel Krovacek
Journal:  Folia Microbiol (Praha)       Date:  2011-09-08       Impact factor: 2.099

6.  Fecal transplant policy and legislation.

Authors:  Dinesh Vyas; Apoorva Aekka; Arpita Vyas
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

7.  Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection.

Authors:  Rana E El Feghaly; Jennifer L Stauber; Elena Deych; Carlos Gonzalez; Phillip I Tarr; David B Haslam
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

8.  Fecal calprotectin concentrations in cancer patients with Clostridium difficile infection.

Authors:  Taojun He; Samuel E Kaplan; Luz A Gomez; Xuedong Lu; Lakshmi V Ramanathan; Mini Kamboj; Yi-Wei Tang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-21       Impact factor: 3.267

9.  Toxigenic Clostridium difficile PCR ribotypes from wastewater treatment plants in southern Switzerland.

Authors:  Vincenza Romano; Vincenzo Pasquale; Karel Krovacek; Federica Mauri; Antonella Demarta; Stefano Dumontet
Journal:  Appl Environ Microbiol       Date:  2012-07-13       Impact factor: 4.792

10.  A multicentre randomised controlled trial evaluating lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea in older people admitted to hospital: the PLACIDE study protocol.

Authors:  Stephen J Allen; Kathie Wareham; Caroline Bradley; Wyn Harris; Anjan Dhar; Helga Brown; Alwyn Foden; Way Yee Cheung; Michael B Gravenor; Sue Plummer; Ceri J Phillips; Dietrich Mack
Journal:  BMC Infect Dis       Date:  2012-05-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.